The role of hematopoietic SCT in adult Burkitt lymphoma
Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma
Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant
Allo-SCT using BU, CY and melphalan for children with AML in second CR
Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan
Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia
Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis
Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT
Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning
GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD
Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantation
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation
Safety and efficacy of rituximab in steroid-refractory chronic GVHD
Recipient seropositivity for adenovirus type 11 (AdV11) is a highly predictive factor for the development of AdV11-induced hemorrhagic cystitis after allogeneic hematopoietic SCT
Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL
Allostimulatory activity of CD133 + hematopoietic cells
BK virus-associated bilateral ureteric stenosis after haematopoietic SCT: viral kinetics and successful treatment
Persistent human rhinovirus type C infection of the lower respiratory tract in a pediatric cord blood transplant recipient